Porton Pharma Solutions Ltd. (300363.SZ)
CNY 14.78
(5.35%)
CNY 14.78
(5.35%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 3.66 Billion CNY | -48.5% |
| 2022 | 7.03 Billion CNY | 126.55% |
| 2021 | 3.1 Billion CNY | 49.87% |
| 2020 | 2.07 Billion CNY | 33.56% |
| 2019 | 1.55 Billion CNY | 30.93% |
| 2018 | 1.18 Billion CNY | 0.07% |
| 2017 | 1.18 Billion CNY | -10.74% |
| 2016 | 1.32 Billion CNY | 29.91% |
| 2015 | 1.02 Billion CNY | 3.44% |
| 2014 | 987.25 Million CNY | 34.44% |
| 2013 | 734.36 Million CNY | 6.45% |
| 2012 | 689.87 Million CNY | 24.85% |
| 2011 | 552.56 Million CNY | 21.22% |
| 2010 | 455.83 Million CNY | 57.98% |
| 2009 | 288.53 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 666.15 Million CNY | -1.13% |
| 2024 Q3 | 773.15 Million CNY | 16.06% |
| 2024 Q1 | 673.78 Million CNY | 7.69% |
| 2023 Q4 | 625.68 Million CNY | -10.39% |
| 2023 Q1 | 1.37 Billion CNY | -24.18% |
| 2023 Q3 | 698.25 Million CNY | -27.34% |
| 2023 Q2 | 960.94 Million CNY | -30.26% |
| 2023 FY | 3.62 Billion CNY | -48.5% |
| 2022 Q2 | 2.47 Billion CNY | 71.28% |
| 2022 FY | 7.03 Billion CNY | 126.55% |
| 2022 Q4 | 1.81 Billion CNY | 39.4% |
| 2022 Q3 | 1.3 Billion CNY | -47.25% |
| 2022 Q1 | 1.44 Billion CNY | 34.17% |
| 2021 FY | 3.1 Billion CNY | 49.87% |
| 2021 Q1 | 542.85 Million CNY | -7.01% |
| 2021 Q4 | 1.07 Billion CNY | 38.93% |
| 2021 Q3 | 773.99 Million CNY | 8.56% |
| 2021 Q2 | 712.95 Million CNY | 31.33% |
| 2020 FY | 2.07 Billion CNY | 33.56% |
| 2020 Q4 | 583.8 Million CNY | 3.73% |
| 2020 Q3 | 562.8 Million CNY | 5.26% |
| 2020 Q2 | 534.69 Million CNY | 36.9% |
| 2020 Q1 | 390.57 Million CNY | -16.86% |
| 2019 Q3 | 456.97 Million CNY | 22.83% |
| 2019 Q4 | 469.8 Million CNY | 2.81% |
| 2019 FY | 1.55 Billion CNY | 30.93% |
| 2019 Q1 | 252.48 Million CNY | -27.48% |
| 2019 Q2 | 372.03 Million CNY | 47.35% |
| 2018 Q2 | 297.65 Million CNY | 40.19% |
| 2018 FY | 1.18 Billion CNY | 0.07% |
| 2018 Q4 | 348.17 Million CNY | 6.57% |
| 2018 Q3 | 326.71 Million CNY | 9.76% |
| 2018 Q1 | 212.31 Million CNY | -40.1% |
| 2017 Q1 | 357.27 Million CNY | -13.39% |
| 2017 FY | 1.18 Billion CNY | -10.74% |
| 2017 Q4 | 354.44 Million CNY | 49.94% |
| 2017 Q3 | 236.39 Million CNY | 0.18% |
| 2017 Q2 | 235.97 Million CNY | -33.95% |
| 2016 Q3 | 301.3 Million CNY | -7.98% |
| 2016 Q2 | 327.44 Million CNY | 14.74% |
| 2016 Q4 | 412.5 Million CNY | 36.91% |
| 2016 FY | 1.32 Billion CNY | 29.91% |
| 2016 Q1 | 285.38 Million CNY | 2.01% |
| 2015 FY | 1.02 Billion CNY | 3.44% |
| 2015 Q4 | 279.76 Million CNY | 36.72% |
| 2015 Q3 | 204.63 Million CNY | -21.01% |
| 2015 Q2 | 259.07 Million CNY | -6.72% |
| 2015 Q1 | 277.72 Million CNY | -32.85% |
| 2014 Q2 | 174.78 Million CNY | -9.49% |
| 2014 Q1 | 193.1 Million CNY | 33.01% |
| 2014 FY | 987.25 Million CNY | 34.44% |
| 2014 Q4 | 413.57 Million CNY | 100.96% |
| 2014 Q3 | 205.79 Million CNY | 17.75% |
| 2013 Q2 | 158.06 Million CNY | -22.8% |
| 2013 FY | 734.36 Million CNY | 6.45% |
| 2013 Q1 | 204.73 Million CNY | 0.0% |
| 2013 Q3 | 226.37 Million CNY | 43.22% |
| 2013 Q4 | 145.18 Million CNY | -35.87% |
| 2012 FY | 689.87 Million CNY | 24.85% |
| 2011 FY | 552.56 Million CNY | 21.22% |
| 2010 FY | 455.83 Million CNY | 57.98% |
| 2009 FY | 288.53 Million CNY | 0.0% |